FDA Fast-Tracked New Alzheimer’s Treatment to Mixed Reviews

Alzheimer’s is a debilitating brain disorder affecting memory and, eventually, language, reasoning, and social behavior. Diagnosed in nearly 6.2 million Americans, Alzheimer’s is a progressive, irreversible disease with treatments mainly focusing on symptoms, such as delaying memory loss, and not the underlying cause—that is, until now. In June of 2021—just in time for Alzheimer’s Awareness Month—the U.S. Food and Drug Administration (FDA) … Read More

New Test for Alzheimer’s

The New York Times ran an article on August 10, 2010, reporting that a study had been completed showing that a spinal fluid test can predict whether or not a patient has Alzheimer’s.  It is now well known that a person can have this dreaded disease for ten or more years before symptoms appear.  Once the disease has become evident, … Read More